Takeda Pharmaceutical Co Ltd TOKYO STOCK EXCHANGE-TOKYO PRO MARKET:TAK
The leadership team, board of directors, and 10% beneficial owners of Takeda Pharmaceutical Co Ltd, reconstructed from SEC insider filings and proxy statements.
Other Reporting Persons
Other Section-16 reporting persons associated with the issuer.
Bitetti Teresa Marie
—193,148 sharesBUTEL JEAN LUC
—9,700 sharesCLARK IAN T
—9,700 sharesDuprey Lauren Rusckowski
—168,513 sharesFUJIMORI YOSHIAKI
—27,865 sharesFurney Natalie Anne Marie
—191,280 sharesFuruta Milano
—50,100 sharesGILLIS STEVEN
—15,857 sharesHatsukawa Koji
—25,834 sharesHigashi Emiko
—17,800 sharesIijima Masami
—12,801 sharesKim Julie So-Young
—324,729 sharesMARAGANORE JOHN
—7,600 sharesMiyabashira Asuka
—3,000 sharesOrsinger Michel Bruno
—7,600 sharesPacheco Rhonda Janice
—149,252 sharesPignagnoli Agosti Marcello
—144,608 sharesPlatford Giles Richard
—225,239 sharesPlump Andrew Stewart
—594,102 sharesReed Kimberly A.
—8,975 sharesRicci Gabriele
—124,132 sharesShannon Elaine Mary
—57,580 sharesTsusaka Miki
—6,400 sharesWeber Christophe Pierre
—253,433 shares
Recent Form 4 Activity last 90 days
No insider transactions in the last 90 days.
View all insider tradesMethodology
Officers and directors are derived from SEC Forms 3, 4, and 5 filed by reporting persons for this issuer. The roster reflects the most recent disclosed relationship per individual. Officer titles use the issuer-supplied designation from the relationship record.
Independence flags and board committee assignments are sourced from the most recent DEF 14A proxy statement when available. For executive compensation context — base salary, equity grants, performance metrics — refer to the Summary Compensation Table in the issuer's annual proxy.
Cross-references: where a reporting person is matched to a consolidated people profile (same CIK across multiple issuers), the person link routes to the unified profile page so you can see every board seat and officer role in one place.